Vaccination
and immunization is aids in prevention of diseases among adults and
children. Vaccines
are biological suspensions that contain an agent that resembles the
disease causing microorganisms and are often made from inactivated
microbes, toxins or surface proteins. The active agents present in
the vaccine stimulates body’s immune system to recognize the
disease causing agent as 'foreign substance' and develop antibodies
against it. Vaccines are a preferable and highly recommended
preventive measure against certain severe diseases, however, have
mild side effects.
Get
Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/1091
Market Dynamics:
Development of vaccines for various new diseases and rising awareness
regarding advantages of preventive medication are the two prominent
factors supporting growth of the market. For instance, according to
the Centers for Disease Control and Prevention, 2015, flu
vaccinations prevented around 1.9 million flu illnesses, 966,000
flu-associated medical visits, and around 67,000 flu-associated
hospitalizations, representing 6.5% lowering of disease burden.
However, high complexity in cost of manufacturing a vaccine is one of
the major factors negatively affecting growth of the market.
Factors such as increasing number of government initiatives to
prevent certain diseases and epidemic caused due to
vaccine-preventable diseases. Additionally, increasing number of
countries are conducting national immunization programs to provide
vaccination and promote awareness regarding advantages of vaccination
to fight fatal diseases with natural immunity among adults as well as
children. For instance, in 2015, the Centers for Disease Control and
Prevention (CDC), the Food and Drug Administration (FDA) and the
National Institutes of Health (NIH) partnered with the U.S.
Department of Health and Human Services Biomedical Advanced Research
and Development Authority (BARDA) to support the advanced development
of new and better influenza vaccines, as a part of inter-agency
government effort in the U.S. Among the middle-income and emerging
economies, relevant Indian government funding agencies such as
Department of Biotechnology (DBT) and The Indian Council of Medical
Research (ICMR) are scaling up their investments in research and
development associated to vaccine development.
Top Key Players:
Key players operating in the global adult vaccines market include
GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc.,
CSL Limited, Johnson & Johnson, Serum Institute of India,
Medimmune, and AstraZeneca Plc.
Detailed Segmentation:
Global Adult Vaccines Market, By Vaccine:
• Influenza
• Tetanus, Diphtheria, Pertussis (Td/Tdap)
• Varicella
• Human Papillomavirus
• Zoster
• Measles, Mumps, Rubella (MMR)
• Pneumococcal
• Hepatitis
• Others
Global Adult Vaccines Market, By Vaccine Type:
• Monovalent
• Multivalent
Global Adult Vaccines Market, By Technology:
• Live Attenuated Vaccines
• Inactivated Viral/Bacterial Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Conjugate Vaccines
Global Adult Vaccines Market, By Geography:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
Get More Information, Talk To our Analyst @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1091
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment